Insider: Rolph Timothy Chief Scientific Officer - Akero Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 166,571 | 0 | 166,571 |
| Value | $7,827,171.29 | $0.00 | $7,827,171.29 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/11/2025 | DDS | 553 | Direct | COM | $43.02 | $23,790.06 | 166,571 |
| 09/08/2025 | DDS | 12,466 | Direct | COM | $44.17 | $550,610.75 | 167,158 |
| 09/08/2025 | DDS | 34 | Direct | COM | $44.88 | $1,525.75 | 167,124 |
| 08/05/2025 | DDS | 5,538 | Direct | COM | $49.07 | $271,721.97 | 174,086 |
| 08/05/2025 | DDS | 6,962 | Direct | COM | $49.49 | $344,577.23 | 167,124 |
| 07/07/2025 | DDS | 10,634 | Direct | COM | $50.93 | $541,610.89 | 168,990 |
| 07/07/2025 | DDS | 1,825 | Direct | COM | $52.00 | $94,892.70 | 167,165 |
| 07/07/2025 | DDS | 41 | Direct | COM | $52.62 | $2,157.30 | 167,124 |
| 06/18/2025 | DDS | 1,129 | Direct | COM | $54.84 | $61,914.36 | 166,234 |
| 06/10/2025 | DDS | 2,358 | Direct | COM | $54.00 | $127,322.57 | 167,363 |
| 06/06/2025 | DDS | 25,000 | Direct | COM | $55.04 | $1,376,000.00 | 169,721 |
| 06/05/2025 | DDS | 3,150 | Direct | COM | $53.84 | $169,596.00 | 169,721 |
| 06/05/2025 | DDS | 9,350 | Direct | COM | $53.37 | $499,037.55 | 172,871 |
| 05/06/2025 | DDS | 3,550 | Direct | COM | $42.26 | $150,037.20 | 178,671 |
| 05/06/2025 | DDS | 300 | Direct | COM | $44.50 | $13,350.90 | 169,721 |
| 05/06/2025 | DDS | 8,650 | Direct | COM | $43.87 | $379,475.50 | 170,021 |
| 04/24/2025 | DDS | 6,250 | Direct | COM | $41.03 | $256,437.50 | 169,721 |
| 04/07/2025 | DDS | 3,750 | Direct | COM | $36.05 | $135,202.50 | 170,021 |
| 04/07/2025 | DDS | 2,200 | Direct | COM | $35.36 | $77,783.20 | 173,771 |
| 04/07/2025 | DDS | 100 | Direct | COM | $36.93 | $3,692.80 | 169,921 |
| 04/07/2025 | DDS | 200 | Direct | COM | $37.92 | $7,583.00 | 169,721 |
| 03/12/2025 | DDS | 516 | Direct | COM | $44.88 | $23,158.08 | 169,721 |
| 03/05/2025 | DDS | 9,338 | Direct | COM | $44.40 | $414,616.54 | 173,399 |
| 03/05/2025 | DDS | 3,162 | Direct | COM | $44.90 | $141,973.80 | 170,237 |
| 02/05/2025 | DDS | 5,903 | Direct | COM | $56.92 | $336,022.37 | 170,237 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research